Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study

被引：0
|
作者：
Yu, J. [1 ]
Wang, J. [2 ]
Sun, X. [1 ]
Wang, L. [3 ]
Ye, M. [4 ]
Feng, P. [5 ]
Zhu, G. [6 ]
Lu, Y. [7 ]
Zhu, S. [8 ]
Liao, Z. [9 ]
机构：
[1] Shandong Canc Hosp, Jinan 250117, Shandong, Peoples R China
[2] Zhengzhou Univ, Canc Hosp, Jinan 250117, Shandong, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Beijing 100730, Peoples R China
[4] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200030, Peoples R China
[5] Jiangsu Canc Hosp, Nanjing, Peoples R China
[6] Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China
[7] Sichuan Univ, W China Hosp, W China Sch Med, Chengdu 610064, Peoples R China
[8] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S315 / S316
页数：2
相关论文
共 50 条
  • [31] Comparing toripalimab combined with chemoradiotherapy versus chemoradiotherapy alone for locally advanced esophageal squamous cell carcinoma: A multicenter, open-label, randomized phase II clinical trial
    Xu, Yujin
    Cheng, Qi
    Wang, Yu
    Zhu, Weiguo
    Huang, Jing
    Du, Dexi
    Tian, Zhifeng
    Yang, Haihua
    Zhou, Chao
    Zhou, Suna
    Sun, Xiaojiang
    Wang, Yuezhen
    Wang, Jin
    Wang, Zhun
    Hu, Xiao
    Chen, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Weekly Chemotherapy with Cisplatin and Paclitaxel and Concurrent Radiation Therapy as Preoperative Treatment in Locally Advanced Esophageal Cancer: A Phase II Study
    Orditura, Michele
    Galizia, Gennaro
    Napolitano, Vincenzo
    Martinelli, Erika
    Pacelli, Roberto
    Lieto, Eva
    Aurilio, Gaetano
    Vecchione, Loredana
    Morgillo, Floriana
    Catalano, Giuseppe
    Ciardiello, Fortunato
    Del Genio, Alberto
    Di Martino, Natale
    De Vita, Ferdinando
    CANCER INVESTIGATION, 2010, 28 (08) : 820 - 827
  • [33] Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer.
    Enzinger, P. C.
    Yock, T.
    Suh, W.
    Fidias, P.
    Mamon, H.
    Choi, N.
    Lehman, N.
    Lawrence, C.
    Lynch, T.
    Fuchs, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 194S - 194S
  • [34] An Open-Label, Phase II, Multicenter, Single-Arm Study of Induction and Concurrent Vismodegib Combined with Curative-Intent Radiation Therapy for Locally Advanced Basal Cell Carcinoma
    Yom, Sue
    Arron, Sarah
    Ho, Alan
    Algazi, Alain
    Dunn, Lara
    Tsai, C. Jillian
    Humphries, Audrey
    Hultman, Carter
    Grekin, Roy
    Knott, P. Daniel
    Barker, Christopher
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S16 - S16
  • [35] Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
    Hui Li
    Ying Fang
    Dayong Gu
    Mingyu Du
    Zhi Zhang
    Lei Sun
    Guoren Zhou
    Jinjun Ye
    Radiation Oncology, 17
  • [36] Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
    Li, Hui
    Fang, Ying
    Gu, Dayong
    Du, Mingyu
    Zhang, Zhi
    Sun, Lei
    Zhou, Guoren
    Ye, Jinjun
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [37] Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
    Hu, Zhihuang
    Sun, Si
    Zhao, Xinmin
    Yu, Hui
    Wu, Xianghua
    Wang, Jialei
    Chang, Jianhua
    Wang, Huijie
    ONCOLOGIST, 2022, 27 (04): : 253 - +
  • [38] Outcomes of concurrent radiation with cisplatin versus cetuximab in locally-advanced head and neck squamous cell carcinoma (LAHNSCC).
    Ly Viet Do
    Dowlatshahi, Morteza
    Parekh, Zayd
    Trevino, Richard
    Eng, Richard
    Fann, Karen
    Dinh, Ngon
    Lee, Raymond W.
    Lee, Charlene Sen-Yee
    Hla, Tin T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] A phase II study of weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC).
    Yun, Fan
    Zhou, Xinming
    Jiang, Youhua
    Chen, Qixun
    Huang, Zhiyu
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [40] A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC)
    Wu, Jennifer J.
    Atkinson, Emily Catherine
    Leichman, Lawrence P.
    Patel, Hitendra
    Iqbal, Syma
    Du, Kevin Lee
    Bizekis, Costas
    Goldberg, Judith D.
    Thomas, Charles R.
    Cohen, Deirdre Jill
    Becker, Daniel Jacob
    Siolas, Despina
    Beri, Nina
    Oberstein, Paul Eliezer
    Ku, Geoffrey Yuyat
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345